Akademska digitalna zbirka SLovenije - logo
E-resources
Full text
Peer reviewed Open access
  • Long‐COVID in people with i...
    Rawlings, Gregg H.; Beail, Nigel

    British journal of learning disabilities, March 2023, Volume: 51, Issue: 1
    Journal Article

    Background Long‐COVID (also known as post‐coronavirus‐19 syndrome) is a term used to describe symptoms that people experience following their recovery from the COVID‐19 virus. The severity of long‐COVID is well recognised, with healthcare providers commissioning services to diagnose and treat those affected, as well as funded research into the condition. Methods We performed a systematic search for relevant articles but were unable to find any research on long‐COVID in people with intellectual disabilities. Due to the lack of data, we have only been able to make extrapolations from what is known about the condition within the general population. Findings We provide an overview of long‐COVID and its potential relevance to people with an intellectual disability. We have focused specifically on symptoms or signs, prevalence, risk factors and treatments of the condition in this group, highlighting areas for clinical practice and future research from a psychosocial perspective. We raise serious questions about our current understanding and the availability of the evidence‐based to inform treatments tailored towards this population. Conclusion This is the first report that we are aware of on the topic of long‐COVID in people with an intellectual disability. The lack of research is preventing us from gaining a greater understanding of how the condition impacts people with an intellectual disability. Accessible summary People with an intellectual disability have been disproportionately affected by the COVID‐19 pandemic. Long‐COVID is a condition in which people continue to experience symptoms after recovering from the COVID‐19 virus. We have been unable to find any research on long‐COVID in people with an intellectual disability. It is not clear what evidence is currently guiding treatments for long‐COVID in this population. More research is needed to investigate the rate, symptoms, risk factors and treatments for long‐COVID in people with an intellectual disability.